Adam M Veness
SVP, General Counsel and Sec. · 4 filings · Latest: Aug 13, 2026
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Aug 13, 2026 | Option Exercise | $18.17 | 15,000 | $272.6K | 15,000 | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Aug 10, 2026 | Sale | $110.38 | 16,167 | $1.8M | 0 | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Aug 10, 2026 | Option Exercise | $17.88 | 16,167 | $289.1K | 16,167 | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Aug 7, 2026 | Sale | $110.70 | 3,833 | $424.3K | 0 | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Aug 7, 2026 | Option Exercise | $17.88 | 3,833 | $68.5K | 3,833 | |
DNTH | ADAM VENESS | — | Aug 10, 2026 | Proposed Sale | $108.92 | 16,167 | $1.8M | — | |
DNTH | ADAM VENESS | — | Aug 7, 2026 | Proposed Sale | $109.92 | 3,833 | $421.3K | — | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Jun 17, 2026 | Sale | $80.80 | 30,000 | $2.4M | 0 | |
DNTH | Adam M Veness | SVP, General Counsel and Sec. | Jun 17, 2026 | Option Exercise | $17.88 | 30,000 | $536.4K | 30,000 | |
DNTH | ADAM M VENESS | — | Jun 17, 2026 | Proposed Sale | $78.88 | 30,000 | $2.4M | — |